Literature DB >> 11175567

[Clinical and nutritional aspects in patients with cystic fibrosis: 20 years of follow-up in the Clinical Hospital-Federal University of Minas Gerais (HC-UFMG)].

F J Reis1, M C Oliveira, F J Penna, M das GR Oliveira, E A Oliveira, A P Monteiro.   

Abstract

BACKGROUND: Cystic fibrosis (CF) is the most common severe autosomal recessive disease in caucasian population. The life expectancy of patients with CF has improved dramatically during the past three decades. A better approach to these patients depends on a better knowledge of clinical course and prognosis of CF. The purpose of the present study was to identify aspects clinical and nutritional on admission at Center of CF (HC-UFMG).
MATERIAL AND METHODS: Over a period of 20 years 127 patients with CF were admitted, submitted to a systematic protocol and prospectively followed. Data associated with demographic conditions, clinical presentation, nutritional and laboratory findings on admission were studied. The median follow-up was 44 months. The genotype was performed by PCR method. The survival analysis was carried out by Kaplan-Meier method.
RESULTS: The median age at diagnosis was 33 months. Sixty-one per cent of patients at diagnosis had chronic pulmonary and gastrointestinal symptoms. Seventeen patients (16%) were homozygous for DF508 mutation and 30 (28%) were heterozygous. There was a standard prevalence of malnutrition of 63% at diagnosis and of 45% at the end of follow up. Twenty patients (15,7%) died during follow up. The estimated probability of survival after one year from diagnosis was 96% and after five years was 80%.
CONCLUSIONS: CF diagnosis has been later in our country and the survival is shorter than in developed countries. Management of cystic fibrosis in pediatric specializing centers results in a better nutritional state in spite of clinical progression of the disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11175567     DOI: 10.1590/s0104-42302000000400031

Source DB:  PubMed          Journal:  Rev Assoc Med Bras (1992)        ISSN: 0104-4230            Impact factor:   1.209


  1 in total

1.  Medications used in pediatric cystic fibrosis population.

Authors:  Stella Pegoraro Alves; Márcia de Azevedo Frank; Denise Bueno
Journal:  Einstein (Sao Paulo)       Date:  2018-11-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.